|
⚲
|
| Keyboard |
| Vensana Capital Management LLC
✚
|
|
|---|---|
| CRD # | 300695 |
| SEC # | 802-114814 |
| CIK # | 0001757539 |
| AUM | |
| Employees | |
| Phone | 612-217-8688 |
| Address | 3601 W 76th St Edina, MN 55435 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [Facebook] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Vensana Capital III LP | [2026-03-16] | 421.6 M | |
| Offered $425,000,000 · Filed 2024-09-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $425,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Vensana Capital II LP | [2022-03-08] | 334.2 M | |
| Offered $300,000,000 · Filed 2021-07-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $300,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Vensana Capital I LP | [2019-02-08] | 228.2 M | |
| Offered $200,000,000 · Filed 2018-12-13 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $200,000,000 · Duration One year or less · Commission $1,200,000 · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Kirk Nielsen | Director, Executive Officer | 47 | 3 | |
| Peter Klein | Director, Executive Officer | 39 | 3 | |
| Vensana Capital III GP LLC | Executive Officer | 1 | 1 | |
| Vmt Fund I GP LLC | Director | 1 | 1 | |
| Vensana Capital II GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001757539] | |
| 4 | [0001757539] | |
| D | [0001757539] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nielsen Kirk G | |
| SpyGlass Pharma Inc | |
| Vensana Capital Management LLC | |
| Vensana Capital I GP LLC | |
| Klein Peter Justin |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 548,067 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Buy | 165,000 | $16.00 | 2,640,000 |
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 359,255 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 1,690,230 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 548,067 | ||
|
SpyGlass Pharma Inc SGP
Series C-2 Preferred Stock · derivative
|
2026-02-09 | Conversion | 3,142,015 | ||
|
SpyGlass Pharma Inc SGP
Series D Preferred Stock · derivative
|
2026-02-09 | Conversion | 2,059,573 | ||
|
SpyGlass Pharma Inc SGP
Series C-1 Preferred Stock · derivative
|
2026-02-09 | Conversion | 3,142,015 | ||
|
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
|
2026-02-09 | Conversion | 9,689,922 |